VA PRIME Care Study Evaluates Pharmacogenomic Tests
Access to Myriad Genetics’ GeneSight test improves depression remission rates according to a new nationwide study of nearly 2,000 veterans conducted by the U.S. Department of Veterans Affairs (VA)
Videos
GeneSight b-roll
Soundbites from GeneSight clinicians
Visuals
Myriad Genetics logo
(full-color, white, and black)